"Breakthrough Antibiotic Kills Drug-Resistant Superbugs in Trials"

Researchers have discovered a new class of antibiotic, zosurabalpin, which effectively kills the deadly drug-resistant superbug, carbapenem-resistant Acinetobacter baumannii (Crab). Zosurabalpin works by blocking a molecular machine that transports a toxin used by Crab, causing the bacteria to die. While the antibiotic is currently in phase 1 clinical trials, it shows promise in combating antibiotic-resistant infections and reducing the emergence of resistance.